| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/24/2000 | CN1253781A CoA oral preparation for reducing blood fat and its preparation method |
| 05/24/2000 | CN1253778A Injection for curing hemorrhoid complicated by anal fistula and its preparation method |
| 05/24/2000 | CN1253777A Medicine composition for curing infantile diarrhea |
| 05/24/2000 | CN1253776A Novel anti-allergic anti-inflammatory composite |
| 05/24/2000 | CN1253775A Refractory vasculitis therapeutic preparation |
| 05/24/2000 | CN1253774A Antiparasitic composite containing N,N-diethyl-m-toluamide |
| 05/24/2000 | CN1253768A Application of cholesteryl liquid crystal polymer as ultraviolet shielding agent in cosmetics and medicine preparation |
| 05/24/2000 | CN1052729C Steroids containing in position 20 aminosubstituted chain, their preparation process and use, and pharmaceutical compositions containing them |
| 05/24/2000 | CN1052726C 7-azabicyclo-[2,2,1]-heptane and-heptene derivatives as analgesics and anti-inflammatory agents |
| 05/24/2000 | CN1052725C Tricyclic vasopressin antagonists |
| 05/24/2000 | CN1052724C Optical active 2,3-dihydro-imidazole and [1,2-C] quinazoline derivative, preparation method and use thereof |
| 05/24/2000 | CN1052723C Bicyclic aromatic compounds as therapeutic agents, its preparing method and drug composition containing said compound |
| 05/24/2000 | CN1052722C Dibenzooxapine or thiapine derivative, its preparing method and drug composition |
| 05/24/2000 | CN1052721C Jinghong goniothalamicin A and its preparation method and use |
| 05/24/2000 | CN1052716C Elemene hydroxyls derivs. and their use as anticancer drugs |
| 05/24/2000 | CN1052654C Anti-senility preparation and preparing method thereof |
| 05/24/2000 | CN1052650C Process for preparing Qingkailing powder injection |
| 05/24/2000 | CN1052633C Medicine for curing hyperplasia of mammary glands |
| 05/23/2000 | US6066765 Acetamidobenzamide compounds for neurodegenerative disorders |
| 05/23/2000 | US6066748 Process of extracting TAXOL® from taxus cuspidata |
| 05/23/2000 | US6066747 Process for the preparation of 9-desoxotaxanes |
| 05/23/2000 | US6066742 Intermediates for the preparation of duocarmycin SA and derivatives thereof, and process for the production of the intermediates |
| 05/23/2000 | US6066739 Process for producing optically active imidazole compounds, intermediates for synthesizing the same, and process for producing the same |
| 05/23/2000 | US6066738 Inhibitors of farnesyl-protein transferase |
| 05/23/2000 | US6066737 Process for the preparation of optically enriched 4-aryl-3-hydromethyl substituted piperidines to be used as intermediates in the synthesis of paroxetine |
| 05/23/2000 | US6066735 Treatment of erectile dysfunction |
| 05/23/2000 | US6066733 Intermediates for viricides |
| 05/23/2000 | US6066730 Boronic ester and acid compounds, synthesis and uses |
| 05/23/2000 | US6066722 Nucleoside analogues used as antiprotozoal agents especially against plasmodium |
| 05/23/2000 | US6066720 Modified oligonucleotides, their preparation and their use |
| 05/23/2000 | US6066678 Alkylated and crosslinked polymer comprises the reaction product of polymers of given formula having amine containing repeat units with at least one aliphatic alkylating agent and a crosslinking agent; administering to remove bile salts |
| 05/23/2000 | US6066677 Use of xylitol and pharmaceutical compositions therefor |
| 05/23/2000 | US6066676 Pharmaceutical composition and methods for using it |
| 05/23/2000 | US6066675 Which cause injury or death of photoreceptors, by administering an alpha-adrenergic agonist |
| 05/23/2000 | US6066673 Enzyme inhibitors |
| 05/23/2000 | US6066671 Topical administration to the eye |
| 05/23/2000 | US6066669 Bactericidal amount of diacetyltartaric acid esters of mono-and diglycerides |
| 05/23/2000 | US6066668 Formulations and methods of reducing toxicity of antineoplastic agents |
| 05/23/2000 | US6066666 Anticonvulsant and anxiolytic lactam and thiolactam derivatives |
| 05/23/2000 | US6066665 Combination of cis-4-hydroxy-L-proline and N-methyl-cis-4-hydroxy-L-proline for use as a therapeutic agent, in particular in cancer treatment |
| 05/23/2000 | US6066664 Method for decreasing the appetite in bulimic, overweight individuals |
| 05/23/2000 | US6066663 Oxidation derivatives of indolylalkylamines and their use as drugs |
| 05/23/2000 | US6066662 Use in control or prevention of rheumatoid arthritis and osteoarthritis or in the treatment of invasive tumours, atherosclerosis or multiple sclerosis |
| 05/23/2000 | US6066659 Reduction in serum lipids, particularly ldl cholesterol |
| 05/23/2000 | US6066657 For the treatment of disease states associated with proteins which mediate cellular activity, for example by inhibiting tumor necrosis factor or phosphodiesterase iv |
| 05/23/2000 | US6066656 2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonamide and anthranilamide subunits and methods of using same |
| 05/23/2000 | US6066655 For the treatment of central nervous system disorders, in particular as cerebral therapeutics |
| 05/23/2000 | US6066654 Methods for treating disorders associated with the central nervous system using optically pure (-) cisapride |
| 05/23/2000 | US6066653 Method of treating acid lipase deficiency diseases with an MTP inhibitor and cholesterol lowering drugs |
| 05/23/2000 | US6066652 Method for treating diseases of the inner ear using adamantane derivatives |
| 05/23/2000 | US6066650 Inhibitors of microsomal triglyceride transfer protein and method |
| 05/23/2000 | US6066649 Erythro-9-(2-hydroxy-3-nonyl)-adenine or 2-o-propoxyphenyl-8-azapurine-6-one, optionally together with one or more activators of guanyl cyclase |
| 05/23/2000 | US6066648 Integrin receptor antagonists |
| 05/23/2000 | US6066647 Zwitterionic forms of trovafloxacin |
| 05/23/2000 | US6066645 Administering an effective amount of the protective agent to a patient receiving one or more antineoplastic agents; compounds useful as protective agents have either a sulfhydryl moiety or are reducible disulfides |
| 05/23/2000 | US6066644 Treatment of various cns disorders |
| 05/23/2000 | US6066643 Administering to said mammal an effective amount of moxonidine, or a pharmaceutically acceptable salt thereof |
| 05/23/2000 | US6066642 For selectively blocking the a3 adenosine receptor of a mammal |
| 05/23/2000 | US6066641 Phosphodiesterases as molecular targets for anti-asthmatic agents |
| 05/23/2000 | US6066640 Hydroxy-halo-quinazolines for augmentation of mast cell bactericidal activity |
| 05/23/2000 | US6066638 Fungicidal pyrimidinones |
| 05/23/2000 | US6066633 Prevent tissue degradation |
| 05/23/2000 | US6066630 Cephalosporin antibiotics |
| 05/23/2000 | US6066629 Dry powder; mixture containing lactamase inhibitor |
| 05/23/2000 | US6066628 Prevent growth of microorganisms |
| 05/23/2000 | US6066627 Steroids as neurochemical initiators of change in human blood levels of LH |
| 05/23/2000 | US6066626 Supplying active human galactosidase to cells |
| 05/23/2000 | US6066625 Enzyme inhibitor; modulators of gene expression |
| 05/23/2000 | US6066624 Gene therapy for solid tumors using adenoviral vectors comprising suicide genes and cytokine genes |
| 05/23/2000 | US6066502 Endothelin converting enzyme (ECE) |
| 05/23/2000 | US6066475 Parathyroid cytosolic autoantigens recognized by autoantibodies from patients with acquired hypoparathyroidism |
| 05/23/2000 | US6066447 Including nucleoside dimers with modified backbones; for viricides and antisense agents |
| 05/23/2000 | US6066340 Process for the preparation of microspheres containing biologically active components |
| 05/23/2000 | US6066339 Controlled release coating of ammonia methacrylate copolymer |
| 05/23/2000 | US6066336 Drying cholestyramine; blending with lubricant; compressing to elongated cylinders with desired thickness; applying protective coating; easy-to-swallow |
| 05/23/2000 | US6066332 Nanoparticles with outer phase of gelatin and/or collagen hydrolyzate |
| 05/23/2000 | US6066327 Antioxidant mixture |
| 05/23/2000 | US6066323 Use of antibodies to sialidase as anti-infectious agents and anti-inflammatory agents |
| 05/23/2000 | US6066319 Administering membrane attack complex (mac) transmembrane channel forming agent which is an antibody simultaneously therewith an effective amount of a therapeutic or diagnostic agent |
| 05/23/2000 | US6066313 Cosmetic compositions |
| 05/23/2000 | US6066229 Method of recycling disk recording medium and apparatus for recovering metal reflective film |
| 05/23/2000 | CA2200959C 2,7-substituted octahydro-1h-pyrido[1,2-a]pyrazine derivatives |
| 05/23/2000 | CA2181089C Piperidine derivatives and process for their production |
| 05/23/2000 | CA2179899C Synthetic glycoamines that promote or inhibit cell adhesion |
| 05/23/2000 | CA2171637C Substituted azaheterocyclecarboxylic acids |
| 05/23/2000 | CA2104873C Compositions and methods of treatment of sympathetically maintained pain |
| 05/23/2000 | CA2048367C Solid oral forms of application containing ifosfamide as active substance |
| 05/23/2000 | CA2029596C Medicaments containing r-a-lipoic acid |
| 05/23/2000 | CA2010578C Piperidine compounds and their preparation and use |
| 05/18/2000 | WO2000028332A1 Methods and compositions to lower plasma cholesterol levels |
| 05/18/2000 | WO2000028323A1 Methods for identifying modulators of bs69 activity |
| 05/18/2000 | WO2000028074A1 Screening process for antibacterial agents |
| 05/18/2000 | WO2000028064A1 Vancoresmycin, a process for its production and its use as a pharmaceutical |
| 05/18/2000 | WO2000028061A2 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same |
| 05/18/2000 | WO2000028059A1 Adenovirus-mediated gene therapy |
| 05/18/2000 | WO2000028046A1 Coffea arabica mannanase |
| 05/18/2000 | WO2000028027A2 Corticosteroid synthesis-associated genes |
| 05/18/2000 | WO2000028020A2 Methods for preventing cardiac hypertrophy and heart failure by inhibition of mef2 transcription factor |
| 05/18/2000 | WO2000028019A2 Antisense oligomer |
| 05/18/2000 | WO2000028003A1 Avipox vector coding an hiv antigen and a cytokine |